Clinical Trial Update: Mesalazine (PENTASA®) in Ulcerative Colitis

View source ↗

Summary

A completed clinical trial update for Mesalazine (PENTASA) in ulcerative colitis, provided by Ferring Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• PENTASA (MESALAMINE)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Ulcerative Colitis | Status: COMPLETED